AL
LJPC

Airain Ltd’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Airain Ltd’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$522K Buy
+17,519
New +$502K 0.02% 532
2016
Q1 		– Sell
-13,451
Closed -$363K – 1275
2015
Q4 		$363K Buy
+13,451
New +$367K 0.03% 546

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Airain Ltd's LJPC Position: Q2 2017 in Review

Airain Ltd opened a new position in La Jolla Pharmaceutical Company (LJPC) in Q2 2017: 17,519 shares worth $522K. The stake represents 0.02% of the portfolio and ranks #532 among its holdings. This is a return to the name: Airain Ltd previously reported a position in LJPC as recently as Q4 2015.

Airain Ltd first reported a position in LJPC in Q4 2015 and has held it in 2 quarters since. 83 funds tracked by Wall St. Rank hold LJPC as of Q2 2017.

  • Airain Ltd held 17,519 shares of La Jolla Pharmaceutical Company worth $522K as of Q2 2017.
  • La Jolla Pharmaceutical Company was a new Airain Ltd position in Q2 2017.
  • La Jolla Pharmaceutical Company made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #532 holding.
  • Airain Ltd first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and has held it in 2 quarters since.
  • 83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.